Zobrazeno 1 - 10
of 200
pro vyhledávání: '"Glen T, Schumock"'
Autor:
Haridarshan Patel, Robert J DiDomenico, Katie J Suda, Glen T Schumock, Gregory S Calip, Todd A Lee
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240379 (2020)
Previous studies have suggested an increased risk of cardiac events with azithromycin, but the predictors of such events are unknown. We sought to develop and validate two prediction models to identify such predictors. We used data from Truven Market
Externí odkaz:
https://doaj.org/article/312a42c11cd24d6dbe81f28b9bca306b
Autor:
Carter D. McCormick, Patrick S. Sullivan, Dima M. Qato, Stephanie Y. Crawford, Glen T. Schumock, Todd A. Lee
Publikováno v:
AIDS Patient Care and STDs.
Autor:
Eric M Tichy, James M Hoffman, Mina Tadrous, Matthew H Rim, Katie J Suda, Sandra Cuellar, John S Clark, Mary Kate Newell, Glen T Schumock
Publikováno v:
American Journal of Health-System Pharmacy.
Purpose To report historical patterns of pharmaceutical expenditures, to identify factors that may influence future spending, and to predict growth in drug spending in 2023 in the United States, with a focus on the nonfederal hospital and clinic sect
Autor:
James M. Hoffman, Matthew H Rim, Katie J. Suda, Michelle D. Wiest, John S. Clark, Mina Tadrous, Linda M. Matusiak, Glen T. Schumock, Sandra Cuellar, Eric M Tichy
Publikováno v:
American Journal of Health-System Pharmacy: AJHP
Purpose To report historical patterns of pharmaceutical expenditures, to identify factors that may influence future spending, and to predict growth in drug spending in 2021 in the United States, with a focus on the nonfederal hospital and clinic sect
Publikováno v:
Therapeutic Innovation & Regulatory Science. 54:424-430
The 2006 FDA's Unapproved Drug Initiative (UDI) aimed to improve safety and public health by decreasing the availability of drug products that never obtained FDA approval (unapproved drug products) in the market and incentivizing manufacturers to emp
Autor:
Kellyn M. Moran, Glen T. Schumock, Todd A. Lee, Gregory S. Calip, Denys T. Lau, Michael J. Koronkowski
Publikováno v:
PharmacotherapyREFERENCES. 41(9)
Background Concomitant use of central nervous system (CNS) medications frequently occurs in older adults with persistent opioid use. The risks of adverse outcomes associated with combinations of opioids, sedative-hypnotics, or skeletal muscle relaxan
Autor:
Glen T. Schumock, Rachel Caskey, Todd A. Lee, Rachel Harrington, Dima M. Qato, James W. Antoon
Publikováno v:
Cancer. 126:649-658
Background Although pediatric cancer survivors in the United States are at an increased risk of developing chronic conditions, to the authors' knowledge there is limited information regarding the types and combinations of conditions they experience i
Autor:
Katie J. Suda, Haridarshan Patel, Robert J. DiDomenico, Glen T. Schumock, Gregory S. Calip, Todd A. Lee
Publikováno v:
JAMA Network Open
This observational cohort study compares the odds of cardiac events among new users of azithromycin relative to new users of amoxicillin using real-world data.
Key Points Question Using a large health care database, what is the risk of cardiac e
Key Points Question Using a large health care database, what is the risk of cardiac e
Autor:
John S. Clark, Katie J. Suda, Matthew H Rim, Michelle D. Wiest, JoAnn Stubbings, Sandra Cuellar, Glen T. Schumock, Linda M. Matusiak, Robert J. Hunkler, Mina Tadrous, James M. Hoffman, Lee C. Vermeulen, Eric M Tichy
Publikováno v:
American Journal of Health-System Pharmacy: AJHP
American Journal of Health-System Pharmacy
American Journal of Health-System Pharmacy
Purpose To report historical patterns of pharmaceutical expenditures, to identify factors that may influence future spending, and to predict growth in drug spending in 2020 in the United States, with a focus on the nonfederal hospital and clinic sect
Publikováno v:
Journal of Oncology Practice. 14:e683-e691
Purpose: Recent cancer drug approvals are lauded as being more effective with relatively fewer adverse effects, but these treatments come with a great cost to the US health care system. There is little information on recent trends in actual antineopl